Long Term Clinical Outcome After Arthroscopic Rotator Cuff Repair Augmentation With Autologous Microfragmented Lipoaspirate Tissue

Exclusion Criteria

• •Partial rotator cuff tendon tears (A1, A2, A3, B1, B2, and B3 according to the SCOI classification)
• •Massive rotator cuff tear (C4 according to the SCOI classification)
• •Subscapularis tendon tear (grade III, IV, or IV according to Lafosse classification)
• •Associated anterior, posterior, or multidirectional shoulder instability
• •Indication for repair of a SLAP lesion of the biceps anchor
• •Grade III or IV muscle atrophy of the supraspinatus and infraspinatus tendons (according to Goutallier or Fuchs classification)
• •Intra-articular hyaluronic acid or corticosteroid infiltration within 3 mo from the planned surgical procedure
• •Medical comorbidities contraindicating arthroscopic shoulder surgery
• •Local (shoulder, abdominal region, gluteal region) or systemic infection, osteomyelitis, or sepsis
• •Diabetes mellitus, untreated thyroid disease, chronic kidney disease, rheumatoid arthritis
• •Immunodeficiency
• •Chronic disorders involving coagulation, platelet aggregation, or severe coagulopathy
• •Severe cardiovascular disease
• •Stroke or acute cardiovascular event within 6 mo from the planned surgical procedure
• •Weight loss for any cause .30 kg in 12 mo or .10 kg in 12 mo without a cause
• •Eating disorders or body dysmorphic disorder
• •Varices, phlebitis, or scars next to the planned adipose tissue harvesting site
• •Alcohol/drug addiction or psychiatric disease compromising compliance with postoperative protocols
• •Pregnancy or breastfeeding women
• •Informed consent not accepted